Nov. 11, 2019
New Results: Brainomix Software shown to improve stroke treatment rates at Budapest University Hospital
Results showed e-Stroke Suite associated with Increase in Thrombolysis and Thrombectomy treatment rates for stroke patients.
Last Friday during a symposium at the annual meeting of the Hungarian Neuroradiology Society (MNRT) in Mátraháza, Dr. Bence Gunda shared results from his hospital which showed that treatment rates for stroke patients improved and treatment times were reduced following the installation of Brainomix’s e-Stroke Suite.
Dr. Gunda is a Neurologist and Associate Professor based at the Department of Neurology at Semmelweis University in Budapest, which treats more than 700 stroke patients each year. As a primary stroke center, Semmelweis is able to deliver intravenous thrombolysis (IVT) to eligible patients. The stroke patients in need of mechanical thrombectomy (MT) treatment are transferred to OKITI in Budapest, where the procedure is performed by a team of trained specialists.
The e-Stroke Suite was installed at Semmelweis in May 2018, enabling the stroke team to automatically assess brain scans from stroke patients using the AI-driven software from Brainomix. To assess the impact of this technology on their stroke service, Dr. Gunda conducted an analysis comparing the same period of time the year prior to the installation of e-Stroke Suite to the period of time when the software was being used.
“The results of our assessment indicated that the treatment rates of both intravenous thrombolysis and mechanical thrombectomy increased once the e-Stroke Suite was installed, with thrombolysis rates increasing from 11.5% to 18.1%, and thrombectomy from 2.8% to 4.8%,” Dr. Gunda noted. “Moreover, there was an improvement in our door-to-needle times, as well as the CT-to-groin-puncture times, both important factors in the treatment pathway for stroke patients,” continued Dr. Gunda.
“The e-Stroke Suite increased our team’s confidence when they are interpreting brain scans, accelerated our decision making, and expedited image sharing with the team at OKITI,” Dr. Gunda observed.
“We are really pleased with the experience that Dr. Gunda and the team at Semmelweis have had with the e-Stroke Suite,” noted Dr. George Harston, Chief Medical & Innovation Officer at Brainomix, who was also presenting at the MNRT Congress in Mátraháza. “Their results are indicative of the impact that our technology can have on a stroke network, helping physicians make faster decisions so that more patients can get the optimum treatment.”
Brainomix’s e-Stroke Suite is the most comprehensive imaging solution, empowering clinicians across all stages of the stroke patient pathway and supporting the thrombectomy decision-making process, from non-contrast CT interpretation, to collateral assessments and LVO detection, to more advanced perfusion-based assessments.